Crossmark

An artificial metabzyme for tumour-cell-specific metabolic therapy

Crossref DOI link: https://doi.org/10.1038/s41565-024-01733-y

Published Online: 2024-08-05

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Xi https://orcid.org/0000-0002-2533-4408
Zhang, Bo https://orcid.org/0000-0002-1579-3707
Zhang, Miao

Liang, Wenshi

Hong, Bangzhen

Ma, Zhiyuan

Sheng, Jianpeng https://orcid.org/0000-0002-5535-5541
Liu, Tianqi

Yang, Shengfei

Liang, Zeyu

Zhang, Jichao https://orcid.org/0000-0002-7400-6726
Fan, Chunhai https://orcid.org/0000-0002-7171-7338
Li, Fangyuan https://orcid.org/0000-0002-8086-7362
Ling, Daishun https://orcid.org/0000-0002-9977-0237
License Information

Text and Data Mining valid from 2024-08-05

Version of Record valid from 2024-08-05
More Information

Article History

Received: 12 October 2023

Accepted: 28 June 2024

First Online: 5 August 2024

Competing interests

: The authors declare no competing interests.